These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [Mass roentgen cataster and carcinoma of the lungs]. BAUER Z Tuberk Erkr Thoraxorg; 1961 Jan; 115():168-71. PubMed ID: 14448522 [No Abstract] [Full Text] [Related]
44. Assessing the efficacy of lung cancer screening. Reich JM Radiology; 2006 Feb; 238(2):398-401. PubMed ID: 16436807 [No Abstract] [Full Text] [Related]
45. Lung cancer screening: radiology's opportunity here and now. Gur D Radiology; 2006 Feb; 238(2):395-7. PubMed ID: 16436806 [No Abstract] [Full Text] [Related]
46. Early Lung Cancer Action Project. Murphy BS; Prull TA Lancet; 1999 Oct; 354(9185):1205. PubMed ID: 10513729 [No Abstract] [Full Text] [Related]
47. THE CODING OF ROENTGEN IMAGES FOR COMPUTER ANALYSIS AS APPLIED TO LUNG CANCER. LODWICK GS; KEATS TE; DORST JP Radiology; 1963 Aug; 81():185-200. PubMed ID: 14053755 [No Abstract] [Full Text] [Related]
48. Lung Cancer in Hungary. Bogos K; Kiss Z; Gálffy G; Tamási L; Ostoros G; Müller V; Urbán L; Bittner N; Sárosi V; Vastag A; Polányi Z; Nagy-Erdei Z; Vokó Z; Nagy B; Horváth K; Rokszin G; Abonyi-Tóth Z; Barcza Z; Moldvay J J Thorac Oncol; 2020 May; 15(5):692-699. PubMed ID: 32340676 [No Abstract] [Full Text] [Related]
49. Mass roentgenographic screening as a lung-cancer-control measure. GUISS LW Cancer; 1955; 8(2):219-36. PubMed ID: 14352162 [No Abstract] [Full Text] [Related]
50. PREVENTION OF CANCER. REPORT OF A WHO EXPERT COMMITTEE. SHAMRAI EF; KHMELEVSKII IuV World Health Organ Tech Rep Ser; 1964; 276():1-53. PubMed ID: 14134351 [No Abstract] [Full Text] [Related]
51. Reporting of Clinical Stage for Lung Cancer: Counterpoint-We Are Not There Yet! Perez-Johnston R; McDermott S AJR Am J Roentgenol; 2022 Jun; 218(6):956-957. PubMed ID: 34910532 [No Abstract] [Full Text] [Related]
52. Curing Early-Stage Lung Cancer: Is There an Easy Way Out? Warner E; Leighl NB J Oncol Pract; 2017 Feb; 13(2):63-65. PubMed ID: 27997303 [No Abstract] [Full Text] [Related]
53. Why does lung cancer so often develop to a lethal stage? LAITINEN H; SAKSANEN S; VIRKKUNEN M Ann Med Intern Fenn; 1963; 52():123-37. PubMed ID: 13928137 [No Abstract] [Full Text] [Related]
55. Author Correction: Differences in lung cancer characteristics and mortality rate between screened and non-screened cohorts. Wu FZ; Kuo PL; Huang YL; Tang EK; Chen CS; Wu MT; Lin YP Sci Rep; 2021 Sep; 11(1):18871. PubMed ID: 34531535 [No Abstract] [Full Text] [Related]
56. HUNCHEST projects-advancing low-dose CT lung cancer screening in Hungary. Kerpel-Fronius A; Bogos K Pathol Oncol Res; 2024; 30():1611635. PubMed ID: 38784857 [TBL] [Abstract][Full Text] [Related]
57. [Reflections on screening tests for lung cancer]. Ostoros G; Ajkay Z; Böszörményi Nagy G; Kovács G Orv Hetil; 1998 Oct; 139(42):2491-4. PubMed ID: 9810162 [TBL] [Abstract][Full Text] [Related]
58. [Risk group chest X-ray for the early detection of lung cancer]. Kovács G Orv Hetil; 2008 May; 149(21):975-82. PubMed ID: 18487112 [TBL] [Abstract][Full Text] [Related]
59. Non-small-cell lung cancer: results of the New York screening program. Heelan RT; Flehinger BJ; Melamed MR; Zaman MB; Perchick WB; Caravelli JF; Martini N Radiology; 1984 May; 151(2):289-93. PubMed ID: 6324279 [TBL] [Abstract][Full Text] [Related]
60. Screening for lung cancer--a review. Kuzniar T; Masters GA; Ray DW Med Sci Monit; 2004 Feb; 10(2):RA21-30. PubMed ID: 14737058 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]